Explore what the biotech rebound means for emerging companies, from renewed investment and pharma partnerships to disciplined growth, flexible lab infrastructure, and capital-efficient operations.

Shared labs offer emerging biotechs a flexible, capital-efficient alternative to leasing or subleasing. Labshares combines lab space, advanced equipment, and operational support with 60-70% cost savings.

Labshares Newton, a shared office and laboratory space for emerging biotechnology and life science companies, announced that it has selected three startup companies developing COVID-19 diagnostics to receive free lab space.